Genentech

News

Roche breaks ground on US manufacturing facility

Roche's Genentech unit has started work on a $700m manufacturing facility in North Carolina, part of a promised $50bn US investment programme.

Market Access

Interview at BIO 2025 with Kyle Touchstone and Laura Rowley

Biotech opportunities in North Carolina, with Kyle Touchston...

From BIO 2025: Kyle Touchstone, director of Economic Development Raleigh and Laura Rowley, director of life sciences development for NCBiotech.

News

Genentech's Bittenbender named board chair at BIO

Genentech's Fritz Bittenbender becomes chair of the Biotechnology Innovation Organization at a challenging time for the sector.

News

Roche ends the 30-year US hiatus in new stroke drugs

Genentech has won FDA approval for its clot-buster TNKase as a treatment for acute ischaemic stroke, after almost abandoning the project in 2023.

News

Genentech buys Regor's next-gen CDK inhibitors for $850M

Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors to Roche's Genentech for an upfront cash payment of $850 million.

News

Roche will relaunch AMD implant Susvimo after update

Roche’s Genentech unit has said will reintroduce its Susvimo implant for eyesight-robbing disease age-related macular degeneration (AMD), which was withdrawn from sale in 2022 due to manufa

Roche breaks ground on US manufacturing facility

Biotech opportunities in North Carolina, with Kyle Touchston...

Genentech's Bittenbender named board chair at BIO

Roche ends the 30-year US hiatus in new stroke drugs

Genentech buys Regor's next-gen CDK inhibitors for $850M

Roche will relaunch AMD implant Susvimo after update

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Genentech

Editor's Picks